Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer

Sima Kadkhodayan; Fateme Homaee Shandiz; Mehdi Seilanian Toussi; Monavar Afzal Aghaee; Farnoosh Farshidi; Parvane Dehghan

International Journal of Cancer Management

The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences

Home

Instructions

APC

Authors Guide Submit Manuscript

Outlines

Abstract
Copyright

Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer

Author(s):

Sima Kadkhodayan¹,

Fateme Homaee Shandiz^2,*,

Mehdi Seilanian Toussi²,

Monavar Afzal Aghaee³,

Farnoosh Farshidi⁴,

Parvane Dehghan⁵

1Women’s Health Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

2Solid Tumor Treatment Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3Dept. of Epidemiology, Mashhad University of Medical Sciences, Mashhad, Iran

4Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

5Dept. of Radiation Oncology, Mashhad University of Medical Sciences, Mashhad, Iran

International Journal of Cancer Management:Vol. 6, issue 4; e80468

Published online:Dec 30, 2013

Article type:Research Article

Received:Jun 30, 2013

Accepted:Sep 03, 2013

How to Cite:Kadkhodayan S, Homaee Shandiz F, Seilanian Toussi M, Afzal Aghaee M, Farshidi F, et al. Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer. Int J Cancer Manag. 2013;6(4):e80468. doi:

Abstract

Background: Concurrent chemoradiotherapy (EBRT + cisplatin) plus intracavitary brachytherapy is the standard of care in patients with advanced cervical cancer. However, a number of patients could not undergone brachytherapy due to massive residual tumor or anatomical distortion. In this study, we have evaluated the treatment outcome in patients with locally advanced cervical cancer, undergone conventional EBRT plus cisplatin based chemotherapy.

Methods: In this study, we have selected patients with locally advanced cervical carcinoma (stage: IIB to IIIB) undergone external beam radiotherapy and chemotherapy without brachytherapy at our institute between October of 2007 and October of 2009. The patients have received 50 Gy within 5 weeks to whole pelvic that has followed by a localized boost dose on tumor to 70 Gy concurrently with cisplatin 35 mg/m2 weekly. The treatment has related toxicities, and survival (overall and disease free) have evaluated.

Results: 30 cases with a median age of 55 (range; 40 to 73) have been studied. According to FIGO classification, the clinical stages were as follows: stage: IIB 23, IIIA 4, and IIIB 3 cases. Three months after treatment, 19 patients (63.3%) have achieved complete response. With a median follow up time of 18 months (range; 10-33 months), 8/23 cases (34.7%) with stage IIB and 2/7 (28.5%) among stage IIIA-IIIB remained disease free at the end of follow up. Data have shown a 2- year overall survival rate of 58.7% ± 9% and 2- year disease free survival of 37.7% ± 9% . Most toxicities were grade I and II. 2 (6.6%) grade III diarrhea and 4 (13.3%) grade III neutropenia have recorded.

Conclusion: Although a considerable number of patients have achieved complete response using concurrent chemoradiotherapy without brachytherapy, the overall treatment outcomes especially for stage IIIA-IIIB were unsatisfactory. Using modern radiation therapy techniques with increased delivered boost dose could improve treatment results.

Keywords

Cervical cancer

Radiotherapy

Concurrent chemoradiotherapy

Fulltext

The Full text is available in PDF.

Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer: A Comparative Retrospective Cohort Study

Malihe Arab,

Fatemeh Dastyar,

Robab Anbiaiee,

Masoomeh Raoufi,

Maryam Hosseini,

Farah Farzaneh

,et al.

Arab M, Dastyar F, Anbiaiee R, Raoufi M, Hosseini M, et al. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer: A Comparative Retrospective Cohort Study. Int J Cancer Manag. 2026;19(1):e168905. doi: https://doi.org/10.5812/ijcm-168905

13

Nov

2024

Comparison of Neoadjuvant Chemotherapy Followed by Radical Surgery with Chemoradiation in Stage IB2 to IIB of Cervical Cancer

Maliheh Arab,

Fatemeh Hadi,

Masoomeh Raoufi,

Robab Anbiaee,

Somayyeh Noei Teymoordash,

Maryam Sadat Hosseini

,et al.

24

Aug

2015

Evaluation of Survival and Treatment Toxicity With High-Dose-Rate Brachytherapy With Cobalt 60 in Carcinoma of Cervix

Afshin Rakhsha,

Amir Shahram Yousefi Kashi,

Seied Mohsen Hoseini

Rakhsha A, Yousefi Kashi AS, Hoseini SM. Evaluation of Survival and Treatment Toxicity With High-Dose-Rate Brachytherapy With Cobalt 60 in Carcinoma of Cervix. Int J Cancer Manag. 2015;8(4):e3573. doi: https://doi.org/10.17795/ijcp-3573

20

Jul

2022

High Dose Rate Brachytherapy Boost After Chemoradiation in Rectal Cancer Patients: A Retrospective Study

Reyhaneh Bayani,

Nima Mousavi Darzikolaee,

Abdol Azim Sadighi Pashaki,

Pedram Fadavi,

Babak Hassanlouei,

Maryam Garousi

Bayani R, Mousavi Darzikolaee N, Sadighi Pashaki AA, Fadavi P, Hassanlouei B, et al. High Dose Rate Brachytherapy Boost After Chemoradiation in Rectal Cancer Patients: A Retrospective Study. Int J Cancer Manag. 2022;15(5):e121298. doi: https://doi.org/10.5812/ijcm-121298

17

Jun

2019

Evaluation of Survival Rate and Non-Fetal Outcomes in Patients with Esophageal Cancer Under Treatment with Neoadjuvant Chemoradiotherapy Plus Additional Platinium-Based Chemotherapy from 2010 to 2016

Hasan Ali Vahedian,

Mohsen Akhondi-Meybodi,

Fatemeh Mansouri,

Masoud Shabani

Vahedian HA, Akhondi-Meybodi M, Mansouri F, Shabani M. Evaluation of Survival Rate and Non-Fetal Outcomes in Patients with Esophageal Cancer Under Treatment with Neoadjuvant Chemoradiotherapy Plus Additional Platinium-Based Chemotherapy from 2010 to 2016. Int J Cancer Manag. 2019;12(6):e89003. doi: https://doi.org/10.5812/ijcm.89003

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 6 days ago
Scopus by Title: 4
Last Update: 6 days ago
Scopus by Title (Ref): 4
Last Update: 6 days ago
CrossRef: 0
Last Update: 3 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Sima Kadkhodayan:[PubMed][Scholar]
Fateme Homaee Shandiz:[PubMed][Scholar]
Mehdi Seilanian Toussi:[PubMed][Scholar]
Monavar Afzal Aghaee:[PubMed][Scholar]
Farnoosh Farshidi:[PubMed][Scholar]
Parvane Dehghan:[PubMed][Scholar]

The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences

Outlines

Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer

Abstract

Fulltext

Similar Articles

Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer: A Comparative Retrospective Cohort Study

Comparison of Neoadjuvant Chemotherapy Followed by Radical Surgery with Chemoradiation in Stage IB2 to IIB of Cervical Cancer

Evaluation of Survival and Treatment Toxicity With High-Dose-Rate Brachytherapy With Cobalt 60 in Carcinoma of Cervix

High Dose Rate Brachytherapy Boost After Chemoradiation in Rectal Cancer Patients: A Retrospective Study

Evaluation of Survival Rate and Non-Fetal Outcomes in Patients with Esophageal Cancer Under Treatment with Neoadjuvant Chemoradiotherapy Plus Additional Platinium-Based Chemotherapy from 2010 to 2016

Last Update: 6 days ago

Last Update: 6 days ago

Last Update: 6 days ago

Last Update: 3 days ago